Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED)

Organon

Status: Completed

Conditions: Rhinitis; Urticaria

Treatments: Drug: Desloratadine

Study type: Observational

Funder types: Industry

Identifiers

NCT00723736

P04446

Details and patient eligibility

About

The objective of this non-interventional study is to evaluate the safety of Aerius syrup in pediatric patients aged 1-5 years old with allergic rhinitis or chronic idiopathic uticaria. The patients will receive 2.5 ml (1.25 mg) once daily.

Full description

Pediatric patients aged 1-5 years

Enrollment: 100 patients

Sex: All

Ages: 1 to 5 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with allergic rhinitis or chronic idiopathic urticaria
• Aged 1-5 years old
• Caregiver's consent to participate

Exclusion criteria

• Healthy individuals
• Younger or older than the 1-5 year old age range

Trial design

100 participants in 1 patient group

Pediatric Patients

Description:

Those with allergic rhinitis or chronic idiopathic urticaria.

Treatment:

Drug: Desloratadine